Development of psoriasis in IBD patients under TNF-antagonist therapy is associated neither with anti-TNF-antagonist antibodies nor trough levels
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of psoriasis in IBD patients under TNF-antagonist therapy is associated neither with anti-TNF-antagonist antibodies nor trough levels
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 51, Issue 12, Pages 1482-1488
Publisher
Informa UK Limited
Online
2016-08-18
DOI
10.1080/00365521.2016.1218541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment
- (2015) Johannan F. Brandse et al. Journal of Crohns & Colitis
- Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study
- (2015) C. Coutzac et al. Journal of Crohns & Colitis
- Biological Treatment of Crohns Disease
- (2013) Ole Haagen Nielsen et al. DIGESTIVE DISEASES
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- (2013) Cornelia Tillack et al. GUT
- Skin Side Effects of Inflammatory Bowel Disease Therapy
- (2013) Joana Torres et al. INFLAMMATORY BOWEL DISEASES
- The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single academic center case series
- (2013) Anita Afzali et al. Journal of Crohns & Colitis
- Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
- (2012) Kavinderjit S Nanda et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases
- (2012) Rafael Denadai et al. Journal of Crohns & Colitis
- Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature
- (2011) G. Cullen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Recent Insights Into the Genetics of Inflammatory Bowel Disease
- (2011) Judy H. Cho et al. GASTROENTEROLOGY
- Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
- (2011) Iván Guerra et al. Journal of Crohns & Colitis
- Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A?systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis
- (2011) Amanda Robinson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
- (2010) Stephan R Vavricka et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy
- (2010) Jean–François Rahier et al. Clinical Gastroenterology and Hepatology
- Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect
- (2010) Marisa Iborra et al. Journal of Crohns & Colitis
- Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
- (2010) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease
- (2009) G. FIORINO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tailoring the length of antiviral treatment for hepatitis C
- (2009) A. Mangia et al. GUT
- Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review
- (2009) Aikaterini-Evaggelia Moustou et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
- Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
- (2008) Angelique N. Collamer et al. ARTHRITIS AND RHEUMATISM
- Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)
- (2008) V. Pittet et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
- (2008) Justin M. Ko et al. JOURNAL OF DERMATOLOGICAL TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More